147 related articles for article (PubMed ID: 26292184)
1. Additive antinociceptive effects of mixtures of the κ-opioid receptor agonist spiradoline and the cannabinoid receptor agonist CP55940 in rats.
Maguire DR; France CP
Behav Pharmacol; 2016 Feb; 27(1):69-72. PubMed ID: 26292184
[TBL] [Abstract][Full Text] [Related]
2. Behavioral Characterization of κ Opioid Receptor Agonist Spiradoline and Cannabinoid Receptor Agonist CP55940 Mixtures in Rats.
Minervini V; Dahal S; France CP
J Pharmacol Exp Ther; 2017 Feb; 360(2):280-287. PubMed ID: 27903642
[TBL] [Abstract][Full Text] [Related]
3. Antinociceptive effects of mixtures of mu opioid receptor agonists and cannabinoid receptor agonists in rats: Impact of drug and fixed-dose ratio.
Maguire DR; France CP
Eur J Pharmacol; 2018 Jan; 819():217-224. PubMed ID: 29183835
[TBL] [Abstract][Full Text] [Related]
4. Interactions between kappa and mu opioid receptor agonists: effects of the ratio of drugs in mixtures.
Minervini V; Lu HY; Padarti J; Osteicoechea DC; France CP
Psychopharmacology (Berl); 2018 Aug; 235(8):2245-2256. PubMed ID: 29785554
[TBL] [Abstract][Full Text] [Related]
5. Age-related differences in sensitivity to the antinociceptive effects of kappa opioids in adult male rats.
Smith MA; French AM
Psychopharmacology (Berl); 2002 Jul; 162(3):255-64. PubMed ID: 12122483
[TBL] [Abstract][Full Text] [Related]
6. Interactive effects of (±)-trans-U50488 and its stereoisomers with cannabinoids.
Erwin LL; Nilges MR; Denys IB; Sutphen JC; Friend AJ; Kapusta DR; Winsauer PJ
Pharmacol Biochem Behav; 2021 Aug; 207():173218. PubMed ID: 34118232
[TBL] [Abstract][Full Text] [Related]
7. Synergistic and additive interactions of the cannabinoid agonist CP55,940 with mu opioid receptor and alpha2-adrenoceptor agonists in acute pain models in mice.
Tham SM; Angus JA; Tudor EM; Wright CE
Br J Pharmacol; 2005 Mar; 144(6):875-84. PubMed ID: 15778704
[TBL] [Abstract][Full Text] [Related]
8. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
Stevenson GW; Folk JE; Linsenmayer DC; Rice KC; Negus SS
J Pharmacol Exp Ther; 2003 Dec; 307(3):1054-64. PubMed ID: 14557380
[TBL] [Abstract][Full Text] [Related]
9. A cellular mechanism for the antinociceptive effect of a kappa opioid receptor agonist.
Ackley MA; Hurley RW; Virnich DE; Hammond DL
Pain; 2001 Apr; 91(3):377-388. PubMed ID: 11275396
[TBL] [Abstract][Full Text] [Related]
10. Antinociceptive and response rate-altering effects of kappa opioid agonists, spiradoline, enadoline and U69,593, alone and in combination with opioid antagonists in squirrel monkeys.
Pitts RC; Dykstra LA
J Pharmacol Exp Ther; 1994 Dec; 271(3):1501-8. PubMed ID: 7996463
[TBL] [Abstract][Full Text] [Related]
11. Kappa antinociceptive activity of spiradoline in the cold-water tail-flick assay in rats.
Briggs SL; Rech RH; Sawyer DC
Pharmacol Biochem Behav; 1998 Jun; 60(2):467-72. PubMed ID: 9632230
[TBL] [Abstract][Full Text] [Related]
12. Modulatory effects of dopamine D3/2 agonists on kappa opioid-induced antinociception and diuresis in the rat.
Cook CD; Barrett AC; Syvanthong C; Picker MJ
Psychopharmacology (Berl); 2000 Sep; 152(1):14-23. PubMed ID: 11041311
[TBL] [Abstract][Full Text] [Related]
13. Interactions between μ-opioid receptor agonists and cannabinoid receptor agonists in rhesus monkeys: antinociception, drug discrimination, and drug self-administration.
Maguire DR; Yang W; France CP
J Pharmacol Exp Ther; 2013 Jun; 345(3):354-62. PubMed ID: 23536317
[TBL] [Abstract][Full Text] [Related]
14. Effects of morphine/CP55940 mixtures on an impulsive choice task in rhesus monkeys.
Minervini V; France CP
Behav Pharmacol; 2018 Feb; 29(1):60-70. PubMed ID: 28952976
[TBL] [Abstract][Full Text] [Related]
15. Interactions between cannabinoid receptor agonists and mu opioid receptor agonists in rhesus monkeys discriminating fentanyl.
Maguire DR; France CP
Eur J Pharmacol; 2016 Aug; 784():199-206. PubMed ID: 27184925
[TBL] [Abstract][Full Text] [Related]
16. Sex and rat strain determine sensitivity to kappa opioid-induced antinociception.
Barrett AC; Cook CD; Terner JM; Roach EL; Syvanthong C; Picker MJ
Psychopharmacology (Berl); 2002 Mar; 160(2):170-81. PubMed ID: 11875635
[TBL] [Abstract][Full Text] [Related]
17. Effects of a kappa agonist, spiradoline mesylate (U62,066E), on activation and vaginocervical-stimulation produced analgesia in rats.
Boyle TJ; Masuda T; Cunningham ST
Brain Res Bull; 2001 Jan; 54(2):213-8. PubMed ID: 11275411
[TBL] [Abstract][Full Text] [Related]
18. Effects of opioid/cannabinoid mixtures on impulsivity and memory in rhesus monkeys.
Minervini V; France CP
Behav Pharmacol; 2020 Apr; 31(2&3):233-248. PubMed ID: 32101988
[TBL] [Abstract][Full Text] [Related]
19. Intake of a palatable sucrose solution modifies the actions of spiradoline, a kappa opioid receptor agonist, on analgesia and feeding behavior in male and female rats.
Kanarek RB; Homoleski BA; Wiatr C
Pharmacol Biochem Behav; 2000 Jan; 65(1):97-104. PubMed ID: 10638642
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological selectivity of CTAP in a warm water tail-withdrawal antinociception assay in rats.
Steinmiller CL; Young AM
Psychopharmacology (Berl); 2008 Jan; 195(4):497-507. PubMed ID: 17882404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]